Depressive symptoms in elderly patients after a somatic illness event - Prevalence, persistence, and risk factors by de Jonge, P. et al.
  
 University of Groningen
Depressive symptoms in elderly patients after a somatic illness event - Prevalence,
persistence, and risk factors
de Jonge, P.; Kempen, G.I.J.M.; Sanderman, R.; Ranchor, A.V.; van Jaarsveld, C.H.M.; van
Sonderen, E.; Scaf-Klomp, W.; Weening, A.; Slaets, J.P.J.; Ormel, J.
Published in:
Psychosomatics
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2006
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
de Jonge, P., Kempen, G. I. J. M., Sanderman, R., Ranchor, A. V., van Jaarsveld, C. H. M., van Sonderen,
E., ... Ormel, J. (2006). Depressive symptoms in elderly patients after a somatic illness event - Prevalence,
persistence, and risk factors. Psychosomatics, 47(1), 33-42.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Original Research Reports
Psychosomatics 47:1, January-February 2006 http://psy.psychiatryonline.org 33
Depressive Symptoms in Elderly Patients After
a Somatic Illness Event
Prevalence, Persistence, and Risk Factors
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JORIS P.J. SLAETS, M.D., PH.D., JOHAN ORMEL, PH.D.
Elderly patients with somatic illness are at increased risk of depression. The authors studied the
prevalence and persistence of depressive symptoms during the first year after the events of myo-
cardial infarction, congestive heart failure, fall-related injury, and the diagnosis of cancer and
their putative pre-event risk factors. The GLAS study contains data from 614 patients who experi-
enced post-baseline myocardial infarction, cancer, heart failure, or fall-related injury of the ex-
tremities within 5 years after the baseline assessment. Follow-up was conducted 8 weeks, 6
months, and 1 year after the somatic event. The authors studied the relative importance of 21
baseline risk factors for experiencing significant depressive symptoms during follow-up and the
persistence of depression. Depressive symptoms were prevalent in 38.3% of the subjects during
the post-event year; in about 19.1%, symptoms were mild. For a majority of patients (67.5%),
symptoms persisted until the next assessment. Significant pre-event risk factors were depressive
symptoms at baseline, age, smoking, poor general health, poor well-being, and neuroticism.
Within the depressed group, only neuroticism was related to the persistence of symptoms. Neurot-
icism increases the risk of experiencing post-event depressive symptoms and is related to their
persistence, which suggests the existence of a depression-prone personality.
(Psychosomatics 2006; 47:33–42)
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Depression is a burdensome disorder with an increasedprevalence in somatic illness (e.g., myocardial infarc-
tion,1 diabetes mellitus,2 congestive heart failure,3 cancer,4
stroke,5,6 hip fracture,7 and other fall-related injuries.8
Since the proportion of elderly persons and, subsequently,
their somatic illnesses, are on the rise, depression is ex-
pected to be among the biggest threats to health in the
coming 25 years.9 Depression is related to poor quality of
life (QoL),10–13 poor recovery after a somatic event,1,13,14
and increased (non-suicide) mortality.15–17 Attention,
therefore, needs to be directed to interventions that may
reduce depression and to clarification of the etiology of
depression, especially in those who are at risk.
Depression and Somatic Illness
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Depression tends to become chronic, and relapses of-
ten occur.11,18–20 Moreover, the hypothetical underlying
mechanisms explaining the relationship between depres-
sion and somatic illness (e.g., the HPA-axis, platelet reac-
tivity, inflammatory processes, inadequate health behavior)
all depend on the chronicity of symptoms.21–23 In support
of this, it was found that in elderly persons living in the
community, only chronic and chronic-intermittent depres-
sion predicted mortality at 3-year follow up.11 A single
depressive episode, in this light, may be seen as a common
reaction to an extremely stressful experience, whereas re-
peated episodes of depression or chronic symptoms may
be related to more stable personality traits, such as neurot-
icism,24,25 which would make subjects more vulnerable to
future episodes. In fact, neuroticism may be regarded as a
“depression-trait,” whereas actual depressive symptoms
may be seen as a “depression-state.” Personality seems to
be of particular interest in elderly people, since Oldehinkel
et al.25 found that neuroticism may mediate the effect of
disability on the development of late-life depression.
Several potential risk factors for depression have been
reported in the literature, such as age,26 sex,27 smoking,28
functional and health status,29,30 personality characteris-
tics,25 and social functioning and support.31 The differential
role of these risk factors remains largely unknown because
the risk factors were rarely studied simultaneously. Be-
cause of their considerable interrelations and/or operational
overlap, their relative importance thus remains unclear. To
study this, a model including as many relevant (i.e., statis-
tically significant) risk factors as possible should be con-
structed, together explaining a maximum amount of vari-
ance. Risk factors for the persistence of depression are
much less studied.32,33
We set out to study the prevalence and persistence of
depressive symptoms and their risk factors in a sample that
was at risk: community-dwelling elderly subjects in the
year after a major somatic event (myocardial infarction,
congestive heart failure, cancer, or fall-related injury). Sub-
jects underwent an extensive baseline assessment, includ-
ing many of the well-known risk factors, and depressive
symptoms were repeatedly assessed after the event, so that
risk factors both for the prevalence and persistence of de-
pressive symptoms could be studied. Depression was mea-
sured by use of a self-report rating scale, since depressive
syndromes that do not fulfill rigorous diagnostic criteria
are highly prevalent in elderly persons, and even mild
symptoms of depression in this patient group are already
consequential.34–38 In order to clarify the way that depres-
sion may develop in somatic illness, we investigated which
risk factors for depression in the elderly general population
would hold true in the context of a somatic illness event.
METHODS
Procedures
We used data from the Groningen Longitudinal Age-
ing Study (GLAS), a population-based prospective cohort
study of older persons.39,40 The original study population
consisted of 8,723 persons age 57 and older on January 1st,
1993, who were registered as patients with 27 general prac-
titioners (GPs). A total of 3,214 refused to participate in
the study; 152 had died or left the practice before contact,
and 78 were excluded because of severe cognitive impair-
ment, leaving a baseline sample of 5,279 subjects. During
the baseline wave in 1993 until January 1st, 1998, the GPs
provided the names of all patients who experienced a post-
baseline episode or diagnosis of acute myocardial infarc-
tion (AMI), congestive heart failure (CHF), cancer, or fall-
related injury of the extremities. The (suspected)
occurrence of cancer was reported by the GPs and checked
with the medical specialists and registration of the Com-
prehensive Cancer Centre North, in the Netherlands. Sub-
jects with less serious forms of cancer, such as basal cell
carcinoma, were excluded. The most frequent diagnoses
within the group of subjects with cancer were breast cancer,
cancer of the intestines, lung cancer, and prostate cancer.
The other conditions were diagnosed according to the cri-
teria of the International Classification of Primary Care
(ICPC).41 To fulfill the diagnosis of injury of the extremi-
ties that needed medical treatment, subjects had to fulfill
one of the ICPC codes L72-L80 (hip fractures; fractures of
wrist or forearm; ankle or lower leg; and hand or foot; and
ankle sprains, knee sprains, or other sprains and disloca-
tions) except for code L79, comprising only minor injuries
at different places (bruises, abrasions). AMI (code K75)
was diagnosed if two of the following findings were pres-
ent: 1) chest pain characteristic of myocardial ischemia and
lasting more than 15 minutes; 2) abnormal ST–T changes
or Q-waves on an ECG; or 3) elevation of blood cardiac
enzymes. CHF (code K77) was diagnosed if three of the
following five clinical manifestations were present: 1) de-
pendent edema; 2) raised jugular venous pressure or he-
patomegaly in the absence of liver disease; 3) signs of pul-
monary congestion or pleural effusion; 4) enlarged heart;
and 5) dyspnea in the absence of pulmonary disease. Of
patients that experienced more than one of the episodes or
diagnoses during the follow-up period, the first illness
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Psychosomatics 47:1, January-February 2006 http://psy.psychiatryonline.org 35
event was chosen. Follow-up consisted of three assess-
ments, consisting of semistructured interviews and self-re-
port questionnaires, administered at approximately 8
weeks, 6 months, and 12 months after the date of the so-
matic event, conducted at the respondents’ homes.
Assessments
Depressive symptoms were assessed with the Hospital
Anxiety and Depression Scale (HADS).42,43 The HADS
does not contain items referring to physical symptoms such
as sleeping problems and weight loss, and it is therefore
suitable for use in subjects with somatic illnesses. The De-
pression subscale consists of 7 items (5 positive, 2 nega-
tive) to be rated by the subject on a 4-point scale (0–3),
with a score range of 0 (no symptoms) to 21 (maximum
number of symptoms; 0.71). A score of 0–7 indicates
a normal score; 8–10 indicates mild symptoms; 11–14,
moderate; and 15–21, severe symptoms of depression.42,43
We constructed a binary variable reflecting whether the
subject had at least mild depressive symptoms (HADS7)
at any of the three follow-up assessments, and a variable
reflecting the severity of depressive symptoms by the max-
imum HADS score during follow-up. When significant de-
pressive symptoms were present at 8 weeks or 6 months
and were still present at least at one of the later follow-up
assessments, they were considered persistent.
Risk Factors
We studied the effects of 21 baseline risk factors, di-
vided into nine categories:
1. Sociodemographic characteristics: Sex, age, having a
partner, educational level, height, and weight were as-
sessed in the baseline interview with the patient. Level of
education was derived from the International Standard
Classification of Education by UNESCO, consisting of
six categories, ranging from kindergarten to higher edu-
cation. “No partner” was defined as being widowed, di-
vorced, or single.
2. Health behavior: The Quetelet Index was calculated
by dividing weight by height height. It was then recoded
as Healthy (QI: 20–25), Fairly Healthy (QI: 26–30 or20),
and Unhealthy (QI30). Smoking was scored in an inter-
view with the patient and recoded into three groups: never
smoked or stopped10 years ago, stopped10 years ago,
and smoking.
3. Somatic comorbidity: We scored the number of self-
reported chronic illnesses for which, in the 12 months pre-
ceding baseline measurement, medical treatment was re-
quested. The number of baseline chronic medical
conditions was assessed by counting the presence of any
of the following 19 diagnoses: asthma/chronic bronchitis,
pulmonary emphysema, heart disease, hypertension, mi-
graine/chronic headache, (consequences of) stroke, leg ul-
cer, stomach ulcer, rheumatoid arthritis, (other) back prob-
lems/joint conditions, diabetes mellitus, liver disorder or
gallstones, prostate disease, kidney disease, thyroid gland
disorder, serious dermatological disorders like psoriasis
and eczema, cancer, multiple sclerosis, and Parkinson’s
disease or epilepsy.44
4. Physical functioning: We used the scales of the Gron-
ingen Activity Restriction Scale (GARS),45 the Medical
Outcomes Study Short Form-20 (MOS SF-20),46 and the
Symptoms Check List–90 (SCL–90).47 The Physical Func-
tioning scale of the MOS SF-20 measures global physical
limitations; it consists of 6 items (two categories each;
0.79) and ranges from 0 to 100. Higher scores indicate
better physical functioning. The GARS consists of 18 items
reflecting self-reported problems with aspects of self-care
and household-related work. Scores range from 18 (no
physical dysfunctioning) to 72 (maximum level of physical
dysfunctioning; 0.93). The SCL–90 Somatic Com-
plaints subscale consists of 12 variables, with 5 answering
categories each. The score reflects self-reported complaints
and physical limitations during the last 7 days.
5. Well-being: With Cantril’s ladder,48 respondents indi-
cate their general well-being, ranging from 0 (worst pos-
sible life) to 10 (best possible life). The MOS SF-20 Gen-
eral Health Perception scale consists of 5 items (5
categories each), in which respondents indicate their gen-
eral health. The score ranges from 0 to 100, and higher
scores indicate better functioning.
6. Social functioning: Social support was measured by
the Social Support List-I (SSL-I),49 which measures social
skills in three dimensions; affect, support with problems,
and appreciation. Total scores range from 12 to 48
(0.83). Social network was measured by the living ar-
rangements and total network of each patient: partner and
living arrangements with those over the age of 18, children
(including foster and stepchildren), neighbors over the age
of 18, and other contacts over the age of 18. For all network
members who do not live with the respondent, type of re-
Depression and Somatic Illness
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lationship and frequency of contact were measured. The
frequency of contacts varied between a score of 1 (less than
once per year) to 9 (daily contact). The Social Functioning
scale of the MOS SF-20 consists of a single item, with 6
answering categories, reflecting the level in which the sub-
ject experienced limitations in his or her social contacts
because of health problems during the last 4 weeks. Total
scores ranges from 0 to 100.
7. Emotional dysfunction: Depressive symptoms and
symptoms of anxiety were assessed at baseline with the
Dutch-validated version of the Hospital Anxiety and De-
pression Scale (HADS; see above).42,43
8. Personality: Neuroticism was assessed with the Neu-
roticism subscale of the Revised Eysenck Personality
Questionnaire (EPQ–R).50 The scale consists of 12 items
that can be answered Yes/No, and the score reflects the
subject’s tendency to emotional instability. Total scores
range from 0 to 12 (0.82). Extroversion was assessed
with the Extroversion subscale of the Revised Eysenck Per-
sonality Questionnaire (EPQ–R). The scale consists of 12
items that can be answered Yes/No, and the score reflects
the tendency of the subject to impulsiveness and social
interest. Total score ranges from 0 to 12 (0.83).
9. Psychological resources: Mastery, which reflects one
of the subject’s psychological coping resources, was mea-
sured by means of a 7-item scale developed by Pearlin et
al.,51 with scores ranging from 7 to 35 (0.79). The scale
assesses the extent to which the person experiences per-
sonal control. Self-efficacy was measured by means of a
16-item test, with 5 answering categories each (Completely
Agree, Agree, Neutral, Disagree, Disagree Completely),
developed by Sherer et al.52 and translated into Dutch by
Bosscher et al.53 The scale assesses the extent to which
subjects have confidence in their own capabilities; score
range from 16 to 80 (0.84).
Subjects
Of the original baseline sample, 1,124 subjects
(21.3%) fulfilled the criteria of one of the four somatic
events (207 diagnosed as AMI, 293 as CHF, 287 as injury
of the extremities, and 337 as cancer). Of these subjects,
480 were excluded because of death, cognitive problems,
or refusal, and 30 for other reasons, leaving 614 partici-
pants (Table 1). Details on the selection of patients in the
specific samples can be found elsewhere (AMI and CHF
sample,54 injury sample,55 cancer sample,56).
Data on depressive symptoms were available for 601
patients at 8-week follow-up, for 559 at 6-month follow-
up, and 516 patients at 1-year follow-up, resulting in com-
plete follow-up for 480 of the 644 participants (74.5%).
Reasons for lost-to-follow-up status were the following:
patient died (N30), patient too sick (N21), patient re-
fused (N25), proxy refused/too sick (N50), other/un-
known (N38). In order to prevent bias by excluding sub-
jects with missing data, which is expected to be
nonrandom, we used the multiple imputation technique to
estimate missing data for all patients who dropped out ex-
cept for those who died. Multiple-imputation technique is
the most valid method to account for nonrandom attrition
because it takes into account that missing data are often
not random, but that estimations can be made on the basis
of related variables.57 Multiple estimations are generated,
resulting in multiple data sets that are analyzed. The results
of the data analyses are combined, taking into account the
level of error generated by the estimation of the missing
data. The computer program SOLAS 3.2 ( Statistical So-
lutions Ltd., 2001) was used for imputation and generated
five imputations for each missing datapoint. We used the
available baseline data to estimate baseline depression, and
post-event depression was estimated by means of baseline
data and the previous depression score. This resulted in
data on 614 complete depression assessments, of which
601 had complete risk-factor assessments.
Statistical Analysis
For group comparisons on variables with an approxi-
mately normal distribution, we used t-tests, and, for cate-
gorical data, we used v2 tests. All multivariate data anal-
yses were conducted on the five imputed data sets
(N614). First, we explored which of the initial list of risk
factors were independently predictive of the outcomes, in
order to reduce the extensive list of risk factors. This was
done by means of backward logistic-regression analysis
(criterion for inclusion: p0.05; criterion for exclusion:
p0.20). This resulted in a list of potential risk factors for
the prevalence and for the persistence of depressive symp-
toms. The potential risk factors were then forced into the
regression model. The significance of the risk factors was
tested by means of combined statistics.58 For any parameter
(point-estimate), we calculated the mean of five imputed
data sets. The variance of the parameters was estimated by
combining the corresponding variance of each of the im-
de Jonge et al.
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Living together 24 (3.9)
Not living together 9 (1.5)
Widowed 176 (28.7)
Divorced 23 (3.7)
No partner 21 (3.4)






5 or more 16 (2.7)
Somatic event after baseline
Cancer 165 (26.9)
Fall-related injury 198 (31.2)
Congestive heart failure 157 (25.6)
Acute myocardial infarction 94 (18.3)
puted data sets with the variability of the parameter esti-
mates across the sets. This way, a broader estimate of the
95% confidence interval (CI) is constructed, which ac-
counts for the uncertainty introduced by the estimation of
the missing values.
On the basis of the method developed by Tosteson et
al.,59 for each individual predictor, sufficient power
(b0.80) is reached when the effect on the outcome (de-
pression: prevalent in about 40% of cases) per standard
deviation (SD) increase in predictor has an odds ratio (OR)
of at least 1.3–1.5 for prevalence of depressive symptoms
(N600) and at least 1.6–1.9 for persistence of depressive
symptoms (N200).
RESULTS
Most of the subjects were age 60–80, with a slight over-
representation of women (56%). About one-third had no
chronic illness at baseline; one-third had one chronic ill-
ness; and one-third had multiple chronic illnesses. The
most frequently occurring somatic event in our sample was
fall-related injury (N198; 31.2%), and the least frequent
was AMI (N94; 18.3%).
Depressive Symptoms
Compared with baseline, depressive symptoms were
more prevalent after the somatic events (Table 2). Paired t-
tests of the symptom score resulted in significant differences
between baseline and the 6-month follow-up (t[600] –3.0;
p0.003) and between baseline and 12-month follow-up
(t[558]  –3.2; p0.003); the difference between baseline
depressive symptoms and 8-week follow-up was not signifi-
cant (t[600]  –1.9; p0.053). Similarly, the presence of
significant depressive symptoms increased after the somatic
events (from 20.2%, at baseline, to 22.8%, 23.2%, and
26.9% at the follow-up points). The chi-square test yielded
a p value of 0.06 (v27.6) for this increasing trend.
Of the 614 subjects, 235 subjects (38.3%) experienced
significant depressive symptoms at least at one of follow-
up assessments. For 112 subjects (19.1%), this represented
mild symptoms, for 87 (14.2%), moderate symptoms, and,
for 31 (5.0%), severe symptoms. Of the subjects who did
not report significant depressive symptoms at baseline,
24.4% reported depressive symptoms at least at one of the
follow-up assessments. Of the 200 patients with significant
depressive symptoms within the first 6 months of follow-
up, for a total of 135 subjects (67.5%), the symptoms per-
sisted until the next follow-up assessment.
Risk Factors for the Prevalence of Depressive
Symptoms During Follow-Up
Logistic-regression analysis resulted in the following
12 potential risk factors: age, smoking, Cantril’s ladder,
MOS SF-20 General Health perception, depressive symp-
toms, neuroticism, MOS SF-20 Physical Functioning, mas-
tery, MOS SF-20 Social Functioning, extroversion, having
no partner, and anxiety symptoms. Forcing these potential
factors in one model resulted in nonsignificant ORs for
MOS SF-20 Physical Functioning, Anxiety Symptoms,
and Mastery. The final model (N601) thus consisted of
nine variables (Table 3), of which six reached statistical
significance in the combined-statistics approach.
Table 4 shows that, except for smoking and having no
partner, all risk factors have a significant and monotonous
association with the severity of depressive symptoms. In
contrast to findings in the literature, age had a positive,
rather than negative, relationship with severity of depres-
sive symptoms.
Risk Factors for the Persistence of Depressive Symptoms
Logistic-regression analysis revealed the following nine
potential risk factors: having no partner, number of chronic
Depression and Somatic Illness
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TABLE 3. Pre-Event Risk Factors for Depression (N601)
and Its Persistence (N200)
Variable OR (95% CI) p
Prevalence of depression
Age 1.29 (1.11–1.50) 0.01
Smoking 1.49 (1.14–1.93) 0.01
Cantril’s Ladder of Well-Being 0.82 (0.70–0.97) 0.02
MOS SF-20 General Health 0.98 (0.97–0.99) 0.03
Depressive symptoms 1.21 (1.13–1.30) 0.01
Neuroticism 1.10 (1.02–1.17) 0.02
MOS SF-20 Social Functioning 0.99 (0.98–1.00) 0.14
Extroversion 0.93 (0.87–1.00) 0.07
No partner 1.34 (0.85–2.11) 0.21
Persistence of depression
Cantril’s Ladder of Well-Being 0.78 (0.60–1.00) 0.09
MOS SF-20 Physical Functioning 0.99 (0.97–1.00) 0.09
Neuroticism 1.25 (1.12–1.40) 0.01
Note: OR: odds ratio; CI: confidence interval; MOS: Medical
Outcomes Study.










Mean number of depressive symptoms (SD) 4.5 (3.7) 4.8 (3.9) 5.1 (4.1) 5.2 (4.2) 6.8 (4.2)
Severity of symptoms, %
No 79.8 77.2 76.8 73.1 61.7
Mild 13.0 12.2 12.8 15.4 19.1
Moderate 5.9 8.9 7.7 8.4 14.2
Severe 1.3 1.7 2.7 3.0 5.0
Note: SD: standard deviation.
illnesses, MOS SF-20 Physical Functioning, Cantril’s lad-
der, neuroticism, Quetelet index, SCL–90 Somatic Com-
plaints, depression, MOS SF-20, and social functioning.
Forcing the nine potential risk factors into one model re-
sulted in nonsignificant ORs for no-partner, number of
chronic illnesses, Quetelet index, SCL–90 Somatic Com-
plaints, depressive symptoms, and MOS SF-20 social func-
tioning. The final model (N200) thus consisted of three
variables: MOS SF-20 physical functioning, Cantril’s ladder,
and neuroticism (Table 3), of which only neuroticism
reached statistical significance in the combined-statistics ap-
proach.
Validation of Findings in Non-Imputed Data
With respect to the prevalence of depressive symptoms
during follow-up, social functioning, extraversion, and
having no partner were not independently related to the
outcome variable. Both physical functioning and well-be-
ing were not independently related to the persistence of
significant symptoms, whereas greater neuroticism was.
Replication of these analyses in the non-imputed data set
resulted in highly comparable parameter estimations, the
exceptions being social functioning as a predictor for de-
pression (OR: 0.99; 95% CI: 0.98–1.00; p0.02) and
physical functioning as a predictor for persistence (OR:
0.98; 95%CI: 0.97–0.99; p0.01).
Effect of Neuroticism on Depressive Symptoms
To further assess the effects of neuroticism, we re-
coded the neuroticism score into Low Neuroticism (score:
0–1), Medium Neuroticism (score: 2–4), and High Neu-
roticism (5–12), in a way that the three emerging categories
had approximately equal sizes. Compared with Low Neu-
rotic subjects, subjects in the highest tertile had an almost-
doubled chance of experiencing depressive symptoms
(131/227 [58%] versus 54/210 [26%]; v250.9; p0.01),
and, of the subjects who reported significant symptoms,
the chance that depression persisted also was much higher
(92/112 [82%] versus 24/45 [53%]; v214.8; p0.01).
The association between baseline neuroticism and post-
event prevalence and persistence of depressive symptoms
is shown in Figure 1, revealing an almost “dose–response”
association.
DISCUSSION
Depression is a major health problem, both because of its
high prevalence and its adverse outcomes. In this study, we
measured the prevalence, persistence, and risk factors of
depressive symptoms in a sample of at-risk, elderly sub-
jects experiencing a somatic illness event. A substantial
minority of our sample (38.3%) experienced significant de-
pressive symptoms during the 1-year follow-up period.
About half of the cases concerned mild depressive symp-
toms, and excluding these from the depression cases would
result in prevalence rates that are only slightly increased
de Jonge et al.
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% % % % v2 p
Age 70 years 50.9 62.4 62.1 67.7 8.9 0.03
Current smoker 20.1 24.8 23.0 19.4 1.4 0.70
No partner 32.2 41.9 40.2 45.2 5.9 0.11
Mean (SD) Mean (SD) Mean (SD) Mean (SD) F p
Cantril’s Ladder of Well-Being 7.8 (1.3) 6.6 (1.4) 6.7 (1.6) 5.9 (2.0) 45.9 0.001
MOS SF-20 General Health 71.0 (21.8) 53.0 (22.9) 49.7 (25.1) 47.1 (29.0) 37.1 0.001
Depressive symptoms 3.1 (2.7) 5.7 (3.2) 7.4 (3.8) 9.2 (4.9) 76.3 0.001
Neuroticism 3.0 (2.8) 4.5 (3.3) 5.4 (3.3) 5.8 (3.7) 23.1 0.001
MOS SF-20 Social Functioning 84.6 (23.3) 70.1 (28.3) 62.6 (29.2) 52.9 (38.8) 30.6 0.001
Extroversion 7.2 (3.0) 5.9 (3.2) 5.6 (3.1) 5.2 (3.1) 11.5 0.001
Note: HADS: Hospital Anxiety and Depression Scale; SD: standard deviation; MOS: Medical Outcomes Study.
FIGURE 1. Relationship Between Baseline Neuroticism Score and
Risk of Post-Event Prevalence (N614) and















0 2 4 6 8 10 12
Prevalence
Persistence
compared with elderly subjects living in the community or
younger somatic-illness patients. Compared with baseline
depression, depressive symptoms were only somewhat in-
creased during the 1-year follow-up period, and, especially,
the group of subjects with moderate or severe depressive
symptoms increased. The potential effect of the somatic
event thus seemed to be limited and to be mediated by a
series of other factors. Of the subjects reporting significant
symptoms in the first half-year after the event, a majority
(67.5%) experienced persistent symptoms that were still
present at a later time within the 1-year follow-up. For the
occurrence of significant depressive symptoms at any of
the three follow-up assessments, age, smoking, self-re-
ported well-being and general health, baseline depressive
symptoms, and neuroticism were independent risk factors.
Persistence of significant depressive symptoms was inde-
pendently associated only with neuroticism. Although all
risk factors reported in this study have been described be-
fore in the literature, they have not been studied in a sample
of elderly patients after a somatic event, and not simulta-
neously. Since, in the present study, they were studied si-
multaneously, we can better assess the relative strength of
the relations. We will now discuss the predictors we found.
Numerous epidemiological studies have shown that
smoking is substantially associated with depression. With
regard to the causality of this relationship, much remains
unclear. Only recently, Dierker et al.28 found some evi-
dence for a shared etiology between dysthymia and heavy
smoking, and, elsewhere, this finding has also been sup-
ported for major depression and heavy smoking. It is ar-
gued by Dierker et al. that certain personality traits may
result in vulnerability for the development of depression
and may be responsible for individual differences in nic-
otine response. Self-reported well-being and general health
perception at baseline were also associated with the prev-
alence of post-event depression. The mutual relationship
between self-reported disability, health status, well-being,
and depression has been frequently described in the liter-
ature.60 The present study provides support for an effect of
well-being and health perception on the occurrence of de-
pressive symptoms, independent of the level of depressive
symptoms at baseline. In secondary analyses (not shown),
we found that, especially, these self-report measures of
well-being and health perception prevented an effect of
self-reported disability, probably because disability fuels
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depressive symptoms and perceptions of well-being and
health, as well. In partial support of this, although bivariate
correlations between disability and depressive symptoms
were present, these correlations disappeared when well-
being and health perception were entered into the model.
The reason for the disappearing effect of disability may be
due to the operational similarity between well-being and
depressive symptoms. In line with several studies reported
in a recent metaanalysis,61 we found that the risk of post-
event depressive symptoms increased with age. However,
as mentioned elsewhere, this relationship may be due to
other risk factors, such as physical health problems and
their related disability and activity restriction.25 In our sam-
ple of subjects experiencing a somatic illness event, age
seemed to model the effect of physical dysfunction. First,
age and MOS SF-20 Physical Functioning were highly cor-
related (–0.37). Second, the significant bivariate associa-
tion between age and prevalence of depression disappeared
when MOS SF-20 Physical Functioning was controlled for.
In our model, presented in Table 3, MOS SF-20 Physical
Functioning was excluded because it lost its significance
because of overlap with MOS SF-20 General Health
(r0.50) and MOS SF-20 (r0.52).
The findings in our study suggest that some elderly
persons may already be vulnerable for depressive symp-
toms before the onset of a somatic-illness event. Neuroti-
cism was associated with a higher risk of experiencing de-
pressive symptoms, comparable with subgroup analyses of
the GLAS study.62 Interestingly, it also was the sole risk
factor to be independently associated with the persistence
of symptoms. The multivariate analyses showed that the
effect of neuroticism was independent of the other risk fac-
tors. Remarkably, baseline neuroticism and baseline de-
pressive symptoms emerged as independent risk factors de-
spite their considerable intercorrelation (r0.43). The
bivariate analyses showed the magnitude of the effect:
highly neurotic subjects reported almost twice as many
symptoms of depression in the year after the event, as com-
pared with Low-Neurotic subjects; they had twice the
chance of experiencing depressive symptoms during fol-
low-up, and, if they did, the symptoms were persistent in
a vast majority of subjects. In the literature,24,63,64 neurot-
icism has been interpreted as a marker of “psychobiologi-
cal vulnerability.” According to the dynamic stress-vulner-
ability model,65 vulnerability factors may influence risks
of onset of depressive episodes by the generation of stress-
ful life events (mediation) and amplification of their effects
(modification). Since the subjects in the present study all
experienced a somatic-illness event, the effect of neuroti-
cism on the prevalence and persistence of depressive symp-
toms has to be interpreted as modification: stressful events
in highly neurotic subjects led to an increased risk of a
(persistently) depressive reaction. Interestingly, in recent
years, much attention has been directed to the concept of
frailty in elderly persons and the search for somatic indi-
cators of frailty, such as IL-6.66,67 Future studies are needed
to investigate whether neuroticism may be seen as an in-
dicator for frailty.
The findings should be considered in the light of the
following strengths and weaknesses of the study: First, by
including a large number of subjects at risk, we were able
to obtain a sample of sufficient size. Second, because of
the repeated follow-up assessment in the year after the so-
matic events, we were able to provide data on prevalence
and persistence of depressive symptoms. Third, by using
multiple-imputation techniques, we were able to conduct
the data analysis in the presence of missing data, limiting
a potential bias from selective dropout. The following lim-
itations of the study should be also mentioned: Depressive
symptoms were measured using a symptom rating scale,
and not according to a diagnostic classification system. We
did this because depressive syndromes not fulfilling diag-
nostic criteria are highly prevalent in elderly persons, and
it has been shown that even minimal symptoms of depres-
sion result in disability and worse somatic prognosis. The
disadvantage, however, is that we do not know to what
extent our findings represent depressive disorders. A sec-
ond limitation concerns the time difference between the
baseline assessment and the post-event follow-up, which
has varied between 0 and 5 years. In secondary analyses,
however, we have found no effects of the time difference,
nor of any alterations in the effects of the risk factors when
the time difference was entered in the prediction models.
A third potential limitation was that we studied prevalent,
rather than incident, depression cases, which complicates
the causal interpretation of our findings. However, the fact
that neuroticism had an effect on post-event depressive
symptoms that exceeded and was independent of pre-event
symptoms clearly supports its etiological role. Fourth, we
were not able to consider the role of pain in the relationship
between the predictors and depressive symptoms, nor were
we able to study to what extent our findings may have been
affected by the treatment status of the depression.
The assessment of neuroticism is not standard practice
in clinical care. Still, the present findings do stress that
standard assessment of neuroticism might improve care for
depression. First, neuroticism seems to be an excellent can-
didate measure for the assignment of preventive interven-
de Jonge et al.
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tions in subjects at risk of developing depression. Second,
neuroticism may be used for the allocation of specific in-
terventions to treat depression. For example, for depressed,
highly neurotic subjects, therapy should be directed to
long-term goals and relapse-prevention. More information
of such aptitude/treatment interactions would be needed to
support this claim. It is clear, though, that, in the coming
years, more attention should be directed to adjusting treat-
ment of depression to individual characteristics.68
This research is part of the Groningen Longitudinal
Aging Study (GLAS). GLAS is conducted by the Northern
Centre for Healthcare Research (NCH) and various de-
partments of the University of Groningen in The Nether-
lands. The primary departments involved are Public Health
& Health Psychology, Family Medicine, Psychiatry, Soci-
ology (ICS), and Human Movement Sciences. GLAS and
its substudies are financially supported by the Dutch gov-
ernment (through NESTOR), the University of Groningen,
the Faculty of Medical Sciences, the Dutch Cancer Foun-
dation (NKB/KWF), and the Netherlands Organisation for
Scientific Research (NWO). The central office of GLAS is
located at the NCH, P.O. Box 196, 9700 AD Groningen,
The Netherlands (http://www.med.rug.nl/nch/).
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